NCT07185828

Brief Summary

The goal of this campaign is to reduce unnecessary visits to a Geisinger emergency department (ED). In this campaign, patients will be assigned to receive or not receive outreach following ED discharge with a low-acuity visit designation. Outreach will occur via a text message the day after discharge from the ED as well as information added to the patient's after visit summary (AVS). Depending on the assigned condition, it will include calls to see their primary care provider (PCP) or use an Intelligent Triage tool. The study will assess whether ED use within the following 120 days differs across patients in different outreach conditions (current standard practice vs contact your PCP vs use Intelligent Triage). It will also examine whether patients follow through on the message-specific calls to action differently across conditions.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8,286

participants targeted

Target at P75+ for not_applicable

Timeline
3mo left

Started Apr 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress82%
Apr 2025Aug 2026

Study Start

First participant enrolled

April 15, 2025

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

September 15, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 22, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Expected
Last Updated

March 13, 2026

Status Verified

March 1, 2026

Enrollment Period

1 year

First QC Date

September 15, 2025

Last Update Submit

March 12, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Return to Geisinger ED

    ED visit (yes/no)

    within 120 days following day of discharge

Other Outcomes (8)

  • PCP appointment made

    within 60 days following day of discharge

  • PCP visit

    within 60 days following day of discharge

  • Telehealth appointment made

    within 60 days following day of discharge

  • +5 more other outcomes

Study Arms (3)

Control

NO INTERVENTION

This arm will receive no intervention outside of usual care.

Contact your PCP

EXPERIMENTAL

Intervention content emphasizes contacting a primary care provider (content will vary slightly based on whether the patient has a Geisinger PCP)

Behavioral: Contact your PCP

Use Intelligent Triage

EXPERIMENTAL

Intervention content emphasizes using Intelligent Triage to assess symptoms.

Behavioral: Use Intelligent Triage

Interventions

Text messages will be sent and discharge paperwork will be modified to encourage contacting a primary care provider.

Contact your PCP

Text messages will be sent and discharge paperwork will be modified to encourage using Intelligent Triage.

Use Intelligent Triage

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \>= 18 years of age
  • Geisinger ED visit rated as low acuity (L4 or L5)
  • Discharged from Geisinger ED in past 24 hours

You may not qualify if:

  • Cannot be contacted via the communication modality being used in the study (i.e., SMS), due to insufficient/missing contact information in the EHR or because the patient opted out
  • Admitted to hospital
  • Already included in intervention in past 365 days

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Geisinger

Danville, Pennsylvania, 17822, United States

RECRUITING

MeSH Terms

Conditions

Emergencies

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Amir Goren, PhD

    Geisinger Clinic

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Amir Goren, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Patients will be aware of their own messages but not of messages sent to other patients or in other arms.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 15, 2025

First Posted

September 22, 2025

Study Start

April 15, 2025

Primary Completion

May 1, 2026

Study Completion (Estimated)

August 1, 2026

Last Updated

March 13, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations